1. Home
  2. CF vs BMRN Comparison

CF vs BMRN Comparison

Compare CF & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CF Industries Holdings Inc.

CF

CF Industries Holdings Inc.

HOLD

Current Price

$78.48

Market Cap

11.9B

Sector

Industrials

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$62.05

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CF
BMRN
Founded
1946
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
10.0B
IPO Year
2005
1999

Fundamental Metrics

Financial Performance
Metric
CF
BMRN
Price
$78.48
$62.05
Analyst Decision
Hold
Buy
Analyst Count
15
19
Target Price
$92.21
$88.42
AVG Volume (30 Days)
2.5M
3.0M
Earning Date
11-05-2025
10-27-2025
Dividend Yield
2.56%
N/A
EPS Growth
31.44
59.53
EPS
8.27
2.68
Revenue
$6,736,000,000.00
$3,094,001,000.00
Revenue This Year
$21.13
$13.39
Revenue Next Year
N/A
$7.57
P/E Ratio
$9.47
$19.38
Revenue Growth
12.59
12.39
52 Week Low
$67.34
$50.76
52 Week High
$104.45
$73.51

Technical Indicators

Market Signals
Indicator
CF
BMRN
Relative Strength Index (RSI) 45.65 75.30
Support Level $77.31 $51.50
Resistance Level $79.82 $53.57
Average True Range (ATR) 1.76 1.77
MACD 0.28 0.40
Stochastic Oscillator 58.34 87.07

Price Performance

Historical Comparison
CF
BMRN

About CF CF Industries Holdings Inc.

CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making the company one of the lowest-cost nitrogen producers globally. It is also investing in carbon-free blue and green ammonia, which can be used as an alternative fuel to hydrogen or as a means to transport hydrogen.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: